N. Saelim\'s current address is: Dept. of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, Pitsanulok, Thailand, 65000.

L.M. John\'s current address is: Pfizer, Inc., CVMD Biology, Groton, CT 06340.

Abbreviations used in this paper: ANT, adenine nucleotide translocator; DBD, DNA binding domain; ΔΨ, mitochondrial membrane potential; IP~3~, inositol 1,4,5-trisphosphate; MBS, modified barth\'s solution; O~2~, oxygen; pBOX, three amino acid sequence within the DNA binding domain that recognizes specific DNA binding sequences; RA, 9-cis retinoic acid; rTR~α~1, rat thyroid hormone receptor alpha subtype 1; rTR~α~ΔF1, shortened form of rat TR~α~1; Ru~360~, ruthenium 360; RXR, retinoid X receptor; SEAP, secreted placental alkaline phosphatase; T~3~, 3,5,3′-tri-iodothyronine; TMRE, tetramethylrhodamine ethyl ester; TR, thyroid receptor; TRE, thyroid hormone response element; xTR~β~A1, *Xenopus* thyroid hormone receptor beta subtype A1.

Introduction
============

Thyroid hormones are lipophilic ligands composed of two iodinated tyrosine residues that regulate cellular differentiation and development, cardiac function, and basal metabolism ([@bib1]; [@bib40], [@bib41]; [@bib39]; [@bib29]; [@bib51]; [@bib26]). Thyroid receptors (TRs) are classified as steroid hormone receptors and have genomic effects similar to other nuclear receptors such as glucocorticoid, estrogen, and androgen receptors. Two separate genes encode thyroid hormone receptors α (TR~α~) and β (TR~β~). Alternative splicing or the use of different promoters generates multiple isoforms including the α (TR~α~1, TR~α~2) and β (TR~β~1, TR~β~2) subtypes ([@bib30]). Thyroid hormones have been shown to increase the number of mitochondria and to induce the expression of mitochondrial proteins encoded by both nuclear and mitochondrial genes ([@bib11]; [@bib51]; [@bib27]; [@bib62]; [@bib35]; [@bib48]). Isolated mitochondria from hyperthyroid cells exhibit enhanced substrate cycling and increased oxygen (O~2~) consumption ([@bib52]). Thyroid hormone also affects the mitochondrial membrane potential (ΔΨ) through the expression of mitochondrial proteins ([@bib51],[@bib52]). Collectively, these long-term effects take days or weeks to manifest and are thought to be mediated by nuclear and mitochondrial transcriptional regulation.

Increasing evidence suggests that thyroid hormone exerts nontranscriptional effects on mitochondrial metabolism. Initial studies demonstrated that treatment of cells with 3,5,3′-tri-iodothyronine (T~3~) results in a rapid increase in O~2~ consumption and ATP production in rat liver mitochondria ([@bib53]). These effects persisted in the presence of protein synthesis inhibitors, suggesting that the mechanism of action was nontranscriptional. Sterling and coworkers ([@bib53]; [@bib56]) additionally demonstrated that exposure of mitochondria to T~3~, isolated from rat hepatocytes, increased both ATP production and O~2~ consumption. Acute exposure of isolated mitochondria to thyroid hormone has also been reported to increase ΔpH and to increase mitochondrial Ca^2+^ efflux ([@bib57]; [@bib10]; [@bib51]). Mitochondrial localization of TRs was originally reported by Sterling and coworkers ([@bib55]). Later, [@bib2] identified two high affinity T~3~ binding proteins in rat liver mitochondria. [@bib62] and [@bib9] reported the presence of a high affinity (∼43 kD) T~3~ binding protein in rat liver mitochondrial matrix extracts, which was identified as an NH~2~ terminus shortened form of rat TR~α~1 (rTR~α~ΔF1). The full-length form of the rat thyroid hormone receptor alpha subtype 1 (rTR~α~1) is predominantly localized to the nucleus where it binds to DNA response elements and regulates transcriptional events ([@bib62]). Wrutniak ([@bib62]) suggested that the mitochondrial form of the rTR may be involved in mitochondrial transcriptional activity.

Intracellular Ca^2+^ signaling has been intimately linked to mitochondrial metabolism. Several dehydrogenases within the citric acid cycle are Ca^2+^ dependent ([@bib34]). Ca^2+^ uptake into the mitochondria is a passive process driven by the mitochondrial ΔΨ and occurs via the Ca^2+^ uniporter. Because of the low Ca^2+^ affinity of the uniporter, high cytosolic Ca^2+^ concentrations are required to cause significant mitochondrial Ca^2+^ uptake. Under physiological conditions, these concentrations only occur near an open ion channel pore. Consequently, close physical proximity between the ER and mitochondria is required for significant mitochondrial Ca^2+^ uptake ([@bib43], [@bib44]). Work from our laboratory also demonstrated that mitochondrial Ca^2+^ uptake itself modulated inositol 1,4,5-trisphosphate (IP~3~)-Ca^2+^ release ([@bib28]). Subsequently, [@bib23] demonstrated that IP~3~-mediated Ca^2+^ oscillations efficiently stimulated mitochondrial metabolism. The local Ca^2+^ signaling between the ER and mitochondria has now been supported by many other investigators ([@bib50]; [@bib24]; [@bib59]). Control of mitochondrial metabolism by matrix Ca^2+^ appears to be a fundamental mechanism whereby cells meet their energy requirements.

*Xenopus laevis* oocytes do not express detectable levels of endogenous TRs ([@bib3]; [@bib29]; [@bib14]). Induction of TR expression in *Xenopus laevis* occurs during the embryonic stages of development ([@bib64]; [@bib3]; [@bib29]; [@bib14]). Consequently, *Xenopus* oocytes offer a unique model system to study the effects of thyroid hormones and their receptors on intracellular Ca^2+^ signaling and mitochondrial metabolism.

We present evidence demonstrating that thyroid hormone-activated TRs acutely regulate mitochondrial metabolism and, thereby, Ca^2+^ wave activity. Only expression of the NH~2~ terminus--truncated forms of TR that target the mitochondria were effective at stimulating mitochondria. Transcriptionally inactive TRs were fully capable of modulating Ca^2+^ wave activity. These observations suggest an acute nontranscriptional pathway for modulation of intracellular Ca^2+^ signaling via thyroid hormone receptor-stimulated mitochondrial metabolism.

Results
=======

T~3~-stimulated TR~β~A1s modulate IP~3~-mediated Ca^2+^ wave activity
---------------------------------------------------------------------

Acute nongenomic effects of thyroid hormones occur within minutes of ligand treatment ([@bib25]). To examine the importance of TRs on the nongenomic modulation of intracellular Ca^2+^ signaling, stage VI *Xenopus* oocytes were injected with mRNA encoding the *Xenopus* thyroid hormone receptor betz subtype A1 (xTR~β~A1) as described previously ([@bib8]). Expression of xTR~β~A1 was confirmed by Western blot analysis, 2--3 d after mRNA injection ([Fig. 1](#fig1){ref-type="fig"}). The Ca^2+^ indicator dye was injected into oocytes 30--45 min before confocal imaging. When oocytes were injected with IP~3~, we observed repetitive Ca^2+^ wave activity with interwave periods of 6.62 ± 0.20 s (*n* = 70; [Fig. 1](#fig1){ref-type="fig"}). When xTR~β~A1 expressing oocytes were treated with T~3~ 10 min before IP~3~ injection, the Ca^2+^ wave periodicity increased significantly to 8.40 ± 0.30 s ([Fig. 1](#fig1){ref-type="fig"}, a and c; *n* = 24, P \< 0.0001 ANOVA single factor). Treatment of oocytes with T~3~ by itself did not induce Ca^2+^ release and no detectable changes in basal intracellular Ca^2+^ concentrations were observed. Application of T~3~ ligand to nonexpressing control oocytes, had no effect on the Ca^2+^ interwave period (6.38 ± 0.34 s, *n* = 27, [Fig. 1](#fig1){ref-type="fig"}, a and c). Similarly, xTR~β~A1 expressing oocytes without T~3~ treatment exhibited no change in Ca^2+^ wave periodicity (6.97 ± 0.24 s, *n* = 35). Peak Ca^2+^ wave amplitudes (ΔF/F) for xTR~β~A1-expressing oocytes exposed to T~3~ (0.69 ± 0.04, *n* = 29) was also significantly higher than that of control oocytes exposed to T~3~ (0.55 ± 0.04, *n* = 20; P \< 0.05, *t* test). We conclude from these data that T~3~-stimulated xTR~β~A1 acutely modulates IP~3~-mediated Ca^2+^ wave activity and that both thyroid hormone and receptor expression are required for these effects.

![**T~3~-bound TR** ~**β**~ **A1 increases IP~3~-induced Ca^2^** ^**+**^ **wave period.** (a) Spatial-temporal stacks of IP~3~ (∼300 nM)-induced Ca^2+^ wave activity in a representative control (water injected) oocyte, a T~3~-treated (100 nM) oocyte expressing TR~β~A1 and a T~3~ (100 nM) treated oocyte. Each image is 745 × 745 μm. (b) Western blot showing expression of TR~β~A1. Protein extracts from all groups were collected and loaded at 0.5 oocytes per lane onto 10% SDS-PAGE. The membrane was probed with a monoclonal mouse anti--human TRs antibody (MA1-215) and labeled with an HRP-conjugated secondary antibody. (c) Histogram of average interwave period for each group of oocytes. *n* values in parentheses represent the total number of oocytes pooled from at least two frogs. Error bars correspond to the mean ± SEM. The asterisks (\*\*) denote a statistic significant difference (ANOVA single factor, P \< 0.0001).](200409011f1){#fig1}

Transcriptional activity of TR~β~A1 is undetectable in the absence of xRXR
--------------------------------------------------------------------------

Classically, activated thyroid hormone receptors heterodimerize to initiate transcription responses. Retinoid X receptor (RXR) is the most common dimerization partner that binds to the thyroid hormone response element (TRE; [@bib31]; [@bib4]; [@bib61]). To investigate the transcriptional activity of xTR~β~A1, we coinjected oocytes with xTR~β~A1 mRNA and a plasmid reporting vector containing a TRE system with two direct repeats (DR4) upstream of the secreted placental alkaline phosphatase (SEAP) gene (p-TRE-SEAP; CLONTECH Laboratories, Inc.). If the hormone receptor dimerizes and binds to the TRE enhancer, the oocyte expresses SEAP, which is secreted into the medium. mRNA-injected oocytes were continuously bathed in T~3~ (100 nM) for 3 d and the presence of SEAP was subsequently quantified by Western blot analysis and used as a marker for transcriptional activity. Using this TRE-reporting system, we observed no transcriptional activity in oocytes expressing the xTR~β~A1 protein by itself ([Fig. 2](#fig2){ref-type="fig"} a, lane 3). However, when we coexpressed xRXR~α~ with xTR~β~A1 and oocytes were incubated with T~3~ (100 nM) and 9-cis retinoic acid (RA; 100 nM) for 3 d, SEAP expression was significantly increased ([Fig. 2](#fig2){ref-type="fig"} a, lane 5). Note that xTR~β~A1/xRXR~α~-mediated transcription requires both ligands, T~3~ and RA ([Fig. 2](#fig2){ref-type="fig"} a, lanes 4 and 5). These data indicate that stimulation of xTR~β~A1 by T~3~ does not initiate detectable transcription in *Xenopus* oocytes.

![**Transcriptional activity of TR** ~**β**~ **A1 requires xRXR** ~**α**~ **and both cognate ligands.** Transcriptional activity was monitored with the TRE-reporter vector, pSEAP ^(TRE)^. (a) Lanes 1 and 2 are negative (pSEAP^(−ve)^) and positive (pSEAP^(+ve)^) vector controls. Oocytes expressing TR~β~A1 or TR~β~A1 plus xRXR~α~ were incubated with 100 nM T~3~ (lanes 3--5) plus 100 nM RA (lane 5) for 3 d. Cytosolic extracts from each group of oocytes was prepared and loaded onto a 10% SDS-PAGE at 2.5 oocytes equivalents per lane. SEAP was detected with the polyclonal rabbit anti--human SEAP antibody and an HRP-conjugated secondary antibody. The SP labeled arrow indicates SEAP immunoreactivity, which was present only in oocytes expressing TR~β~A1 and xRXR~α~ exposed to both T~3~ and RA. (b) Transcriptional activity of TR~β~A1 requires the pBOX within the DBD and the NLS. Oocytes expressing xTR~β~A1ΔpBox-NLS and xRXR~α~ show no SEAP immunoreactivity when incubated with T~3~ (lane 6) or T~3~ plus RA (lane 7). Western blot analysis shows that xRXR~α~, TR~β~A1, and xTR~β~A1ΔpBox-NLS are expressed at comparable levels (Western blots below lanes 4--7). TR~β~A1 and xTR~β~A1ΔpBox-NLS were detected with the monoclonal mouse anti--human TRs antibody (MA1-215). xRXR~α~ was detected with a polyclonal rabbit anti--human RXR antibody (Sc-774).](200409011f2){#fig2}

Acute modulation of Ca^2+^ signaling does not require heterodimerization with RXR
---------------------------------------------------------------------------------

To test whether heterodimerization of xTR~β~A1 with xRXR~α~ affects the acute modulation of Ca^2+^ activity, we coinjected oocytes with both xRXR~α~ and xTR~β~A1 mRNA and confirmed protein expression levels using Western analysis 2--3 d after injection of mRNA ([Fig. 3](#fig3){ref-type="fig"} b). Oocytes were loaded with Ca^2+^ indicator dye and confocally imaged. Oocytes coexpressing xTR~β~A1 and xRXR~α~ were initially exposed to both T~3~ (100 nM) and RA (100 nM) 10 min before injection with IP~3~ (∼300 nM). The average Ca^2+^ interwave period for xTR~β~A1-expressing oocytes was 6.58 ± 0.26 s (*n* = 67), whereas that of xRXR~α~/xTR~β~A1 coexpressing oocytes was 6.72 ± 0.31 s (*n* = 82; [Fig. 3](#fig3){ref-type="fig"}, a and c). These values were not significantly different from each other (P = 0.22), but were both significantly larger than values in the control oocytes that exhibited an average Ca^2+^ interwave period of 5.90 ± 0.43 s (*n* = 55, ANOVA single factor, P \< 0.0001; [Fig. 3](#fig3){ref-type="fig"}, a and c). We conclude that the xRXR~α~ coexpression does not affect the ability of T~3~-bound xTR~β~A1 to modulate Ca^2+^ signaling.

![**Acute modulation of Ca** ^2**+**^ **signaling does not require heterodimerization of TR** ~**β**~ **A1 with xRXR** ~**α**~ **.** (a) Spatial-temporal stacks of IP~3~-induced Ca^2+^ wave activity in control oocytes compared with oocytes expressing TR~β~A1 or TR~β~A1 with xRXR~α~. T~3~ (100 nM) and RA (100 nM) were added as indicated 10--15 min before injection with IP~3~ (∼300 nM). Scale is the same as [Fig. 1](#fig1){ref-type="fig"}. (b) Western blots of oocytes expressing TR~β~A1 and xRXR~α~. Primary and secondary antibodies were identical to those used in [Figs. 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}. (c). Histogram of average interwave period (second) of each group of oocytes. The asterisks (\*\*) denote a statistic significance using ANOVA single factor (P \< 0.0001). Values in parentheses represent the number of oocytes.](200409011f3){#fig3}

The DNA binding domain and NLS of TR~β~A1 are not required for acute affects on Ca^2+^ signaling
------------------------------------------------------------------------------------------------

The ability of T~3~-bound xTR~β~A1 to rapidly modulate Ca^2+^ activity suggested a nontranscriptional mechanism of action. Our strategy to test this hypothesis was to delete the DNA binding domain (DBD) and mutate the NLS from the thyroid hormone receptor and test whether the mutant receptors were (a) transcriptionally inactive and (b) still effective at modulating Ca^2+^ signaling. Oocytes were injected with the p-TRE-SEAP plasmid reporting vector. This reporting system requires heterodimerization of xRXR~α~ and xTR~β~A1 to transactivate the reporter gene ([Fig. 2](#fig2){ref-type="fig"} a). Consequently, test oocytes were coinjected with xRXR mRNA with mRNA encoding either wild-type xTR~β~A1 (control), mutant xTR~β~A1 lacking the NLS (xTR~β~A1-ΔNLS), or the mutant lacking both the NLS and the pBOX (xTR~β~A1ΔpBox-NLS). Once injected, oocytes were continuously bathed in T~3~ (100 nM) and RA (100 nM) for 3 d. Expression levels of xTR~β~A1 mutants and xRXR~α~ groups were comparable to xTR~β~A1 and xRXR~α~ groups ([Fig. 2](#fig2){ref-type="fig"} b, bottom). Using the expression of SEAP as a marker for transcriptional activity, we confirmed that oocytes expressing the xTR~β~A1 mutants and xRXR~α~ proteins were transcriptionally inactive, whereas oocytes expressing wild-type xTR~β~A1 and xRXR~α~ proteins exhibited strong transcriptional activity ([Fig. 2](#fig2){ref-type="fig"}, lanes 7 and 5).

Subsequently, we tested whether the transcriptionally inactive xTR~β~A1 mutants could still acutely regulate Ca^2+^ signaling. Oocytes were injected with xTR~β~A1 mRNA or its mutants and protein expression levels were confirmed using Western analysis 2--3 d after injection ([Fig. 4](#fig4){ref-type="fig"} c). Oocytes expressing xTR~β~A1 or the mutants were exposed to T~3~ (100 nM) 10 min before injection with IP~3~ (∼300 nM). Ca^2+^ activity was confocally imaged, as described above. The average Ca^2+^ interwave period for the control group (water-injected oocytes) was 6.6 ± 0.20 s (*n* = 70), which was significantly shorter than that in the xTR~β~A1 expressing oocytes (8.40 ± 0.30 s, *n* = 40; ANOVA single factor, P \< 0.0001; [Fig. 4](#fig4){ref-type="fig"} b, d; [Fig. 1](#fig1){ref-type="fig"}. More importantly, regulation of the Ca^2+^ wave period in oocytes expressing either the single mutant xTR~β~A1-ΔNLS (9.6 ± 0.48 s, *n* = 24) or the double mutant, xTR~β~A1ΔpBox-NLS (8.4 ± 0.28 s; *n* = 24) was indistinguishable from oocytes expressing wild-type xTR~β~A1 ([Fig. 4, b and d](#fig4){ref-type="fig"}). We conclude from these data that neither the pBOX nor the NLS of TR~β~A1 is required for acute regulation of Ca^2+^ signaling.

![**The pBOX and NLSs of TR** ~**β**~ **A1 are not required for the acute regulation of Ca^2^** ^+^ **signaling.** (a) Schematic figure depicting the position of the pBOX deletion in the DBD and the NLS modification within TR~β~A1. (b) Spatial-temporal stack of IP~3~-induced Ca^2+^ wave activity in control oocytes compared with oocytes expressing TR mutants ΔpBox-NLS and ΔNLS. Oocytes expressing the TR mutants were incubated with T~3~ (100 nM) 10--15 min before IP~3~ (∼300 nM) injections. (c) Western blot analysis confirming comparable levels of protein expression for both wild-type and mutant TR~β~A1. (d) Histogram of the average Ca^2+^ wave periods for each group of oocytes (*n* values are in parentheses). Statistic significance over control oocytes is indicated by the asterisks (\*\*; ANOVA single factor, P \< 0.0001).](200409011f4){#fig4}

T~3~-bound TR~β~A1 appears to regulate Ca^2+^ signaling by increasing mitochondrial respiration
-----------------------------------------------------------------------------------------------

We reported previously that pyruvate/malate-energized mitochondria increase the amplitude and interwave period of IP~3~-induced Ca^2+^ waves in *Xenopus* oocytes ([@bib28]). These effects on Ca^2+^ wave activity were similar to those observed in TR~β~A1 overexpressing oocytes with acute T~3~ incubation ([Fig. 1](#fig1){ref-type="fig"}). Sterling and colleagues ([@bib53]) initially reported that T~3~ increases mitochondrial metabolism, particularly oxidative phosphorylation, in less than 30 min. Consequently, we hypothesized that the regulation of Ca^2+^ signaling by T~3~-activated xTR~β~A1 was mediated by its acute modulation of mitochondrial metabolism, which, in turn, increased mitochondrial Ca^2+^ uptake. Our strategy to test this hypothesis was threefold. First, we examined the effect of T~3~ on ΔΨ in TR~β~A1 expressing oocytes using the potential sensitive dye tetramethylrhodamine ethyl ester (TMRE). Oocytes were bathed in 200 nM TMRE for 5 min before imaging fluorescence with two-photon excitation (800 nm). ΔΨ was estimated by monitoring Log(F~mito~/F~cyto~) where F~mito~ is the fluorescence intensity of individual mitochondria and F~cyto~ is the cytosolic fluorescence ([@bib15]). We found that T~3~ significantly increased ΔΨ from a resting value of 0.33 ± 0.01 (*n* = 75) to 0.44 ± 0.01 (*n* = 92, P \< 0.0001) at 5 min and to 0.48 ± 0.02 (*n* = 48, P \< 0.0001) at 25 min ([Fig. 5](#fig5){ref-type="fig"}). These data suggest that T~3~-bound TR~β~A1 regulates Ca^2+^ signaling by increasing ΔΨ. Second, we injected a subgroup of the TR~β~A1-expressing oocytes with ruthenium 360 (Ru~360~; Calbiochem, ∼1 μM final concentration), a polycation that inhibits the electrogenic mitochondrial Ca^2+^ uniporter ([@bib65]) ∼60 min before IP~3~ injection and Ca^2+^ imaging. A control group of TR~β~A1-expressing oocytes were injected with buffer only. We found that Ru~360~ treatment completely inhibited the affect of T~3~-bound TR~β~A1 on Ca^2+^ wave activity ([Fig. 6](#fig6){ref-type="fig"}). Untreated TR~β~A1 expressing oocytes exhibited the expected increase in wave periodicity (7.65 ± 0.4 s, *n* = 11) when preexposed to T~3~ for 10 min. However, the average wave period of Ru~360~-treated TR~β~A1 expressing oocytes was only 5.75 ± 0.22 s (*n* = 13) when preexposed to T~3~. The Ru~360~-treated average was nearly identical to untreated control oocytes (5.59 ± 0.04 s, *n* = 4) as well as Ru~360~-treated nonexpressing oocytes (5.53 ± 0.4 s, *n* = 3). These data are consistent with the hypothesis that T~3~-bound TR~β~A1 regulates Ca^2+^ signaling by increasing mitochondrial Ca^2+^ uptake via an increase in ΔΨ.

![**T~3~ stimulation of oocytes expressing TR** ~**β**~ **A1 increases the ΔΨ.** (a) Images of mitochondria labeled with the potential sensitive dye TMRE. The oocytes are expressing TR~β~A1 and have been exposed to T~3~ for the indicated amount of time. Images are 50 × 100 μm. (b) Histogram of the log of mitochondrial TMRE fluorescence (F~mito~) divided by the cytosolic fluorescence (F~cyto~) at the indicated times of T~3~ exposure. Values in parentheses refers to the number of mitochondrion analyzed. Statistical significance is indicated by the asterisks (\*\*; ANOVA single factor, P \< 0.001).](200409011f5){#fig5}

![**Ru** ~360~ **blocks T~3~-bound TR** ~**β**~ **A1 increases in IP~3~-induced Ca^2^** ^**+**^ **wave period.** (a) Spatial-temporal stacks of the effect of Ru360 treatment on Ca^2+^ wave activity in control oocytes compared with oocytes expressing TR~β~A1as labeled. (b) Histogram of average interwave period (seconds) of each group of oocytes shown in a. The asterisk (\*) denotes a statistic significance using ANOVA single factor (P \< 0.01). Values in parentheses represent the number of oocytes.](200409011f6){#fig6}

Third, we directly test whether thyroid hormone receptor together with T~3~ stimulates mitochondrial respiration. *Xenopus* oocytes were injected with TR~β~A1 mRNA or water and incubated for 3 d. The rate of O~2~ consumption was measured as an indicator of respiration. 200 oocytes in each group were loaded into a 2-ml O~2~ probe chamber filled with modified barth\'s solution (MBS) solution. After 15 min of stabilization, the medium was exchanged with fresh MBS and O~2~ consumption was monitored for 30 min. The medium was exchanged a third time with MBS containing 100 nM T~3~ and O~2~ consumption was followed for another 30 min ([Fig. 7](#fig7){ref-type="fig"}, a and b). After this protocol, the rate of O~2~ consumption in water-injected oocytes after T~3~ exposure was 0.42 ± 0.25 nmol/min (*n* = 8). In contrast, the rate of O~2~ consumption in TR~β~A1-injected oocytes after T~3~ exposure was significantly increased to 1.68 ± 0.52 nmol/min (*n* = 4, P \< 0.05). These data support the hypothesis that a T~3~ / TR~β~A1-mediated increase in mitochondrial respiration was responsible for the modulation of IP~3~-mediated Ca^2+^ wave activity.

![**T~3~ stimulation of oocytes expressing TR** ~**β**~ **A1 increases O~2~ consumption.** (a) Plots of O~2~ levels in oocytes as labeled (*n* = 200 oocytes per group). (b) Histogram represents average change of O~2~ consumption rates (before and after T~3~ exposure) in control and xTR~β~A1 groups. Statistical significance is indicated by the asterisk (\*; *t* test, P \< 0.05).](200409011f7){#fig7}

TRs targeted to the mitochondria are required for a T~3~-stimulated increase in respiration and the regulation of Ca^2+^ signaling
----------------------------------------------------------------------------------------------------------------------------------

T~3~ treatment has previously been reported to increase mitochondrial metabolism ([@bib57]; [@bib51]). Our data suggest that the acute effects of T~3~ on mitochondrial metabolism are likely to be mediated by T~3~-activated thyroid hormone receptors. A truncated form of rat TR~α~1 (rTR~α~1ΔF) has been shown to localize to mitochondria matrix ([@bib2]; [@bib62]; [@bib9]). Furthermore, the NH~2~ terminus of the *Xenopus* TR~β~A1 that we used throughout this work has a high homology to the NH~2~ terminus of rTR~α~1ΔF ([Fig. 8](#fig8){ref-type="fig"} a). Our strategy in this experiment was to test whether mitochondrial targeting of TRs was necessary to modulate Ca^2+^ signaling. First, we examined the cellular targeting of xTR~β~A1, rTR~α~1, and rTR~α~1ΔF by injecting *Xenopus* oocytes with their respective mRNAs. After 3 d of expression, mitochondria were isolated by centrifugation. Whole oocyte extract (minus mitochondria) and mitochondrial extract from each group were subjected to immunoprecipitation using a TR antibody (MA1-215; Affinity BioReagents, Inc.). The immunocomplexes (TRs/MA1-215) were loaded onto a 10% SDS-PAGE gel for Western blot analysis. As shown in [Fig. 8](#fig8){ref-type="fig"} c, only xTR~β~A1 and rTR~α~1ΔF were detected in the mitochondria extracts. Full-length rTR~α~1 did not localize to mitochondria. These results are consistent with previous reports ([@bib2]; [@bib62]; [@bib9]). Our next step was to compare the rate of O~2~ consumption for oocytes expressing either rTR~α~1 or rTR~α~1ΔF ([Fig. 9](#fig9){ref-type="fig"}). Consistent with its mitochondrial targeting, the rate of O~2~ consumption in rTR~α~1ΔF expressing oocytes after T~3~ exposure was significantly increased 1.88 ± 0.35 nmol/min (*n* = 3, P \< 0.05). In contrast, the rate of O~2~ consumption in oocytes expressing the full-length rTR~α~1 was not significantly affected by T~3~ exposure (−0.16 ± 0.55, *n* = 3). We conclude that mitochondrial targeting of TRs is required for a T~3~ mediated increase in mitochondrial respiration.

![***Xeno*pus TR** ~**β**~ **A1 and NH~2~-terminal truncated rat TR** ~**α**~ **1 (rTR** ~**α**~ **1ΔF) localize to mitochondria.** (a) Schematic diagram of TRs showing that rTR~α~1ΔF and xTR~β~A1 have a similar NH~2~ terminus. (b and c) Western blots of TR~α~1, rTR~α~1ΔF, and xTR~β~A1 expression in whole oocytes and mitochondrial extracts respectively. FL, full-length receptor; SH, shortened form of the receptor. Extracts were prepared from 300 oocytes in each group. All oocytes were exposed to 100 nM T~3~ for at least 15 min before organelle extraction. TRs were immunoprecipitated with a monoclonal mouse anti--human TRs antibody (MA1-215), captured with immobilized protein G, concentrated, and loaded onto a 10% SDS-PAGE. An HRP-conjugated secondary antibody was used for visualization.](200409011f8){#fig8}

![**NH** ~2~ **-terminal truncated rat TR** ~**α**~ **1 (rTR** ~**α**~ **1ΔF) stimulates O~2~ consumption.** (a) Plots of O~2~ levels for oocytes expressing full-length rTR~α~1 with and without T~3~ compared with oocytes expressing the NH~2~-terminal truncated rTR~α~1ΔF with or without T~3~. Protocols used were identical to those described in [Fig. 7](#fig7){ref-type="fig"}. (b) Histogram of the average change of the O~2~ consumption rates after T~3~ exposure in rTR~α~1 versus rTR~α~1ΔF groups. The asterisk (\*) indicates statistical significance (*t* test, P \< 0.05).](200409011f9){#fig9}

Finally, we tested whether targeting of TRs to mitochondria was required to regulate Ca^2+^ signaling. As before, oocytes were injected with either full-length rTR~α~1 or NH~2~ terminus--truncated rTR~α~1ΔF mRNAs. Protein expression levels were measured 2--3 d after injection ([Fig. 10](#fig10){ref-type="fig"} b). Ca^2+^ activity was confocally imaged 10 min after treatment with T~3~ (100 nM). We found that the average Ca^2+^ interwave period for rTR~α~1ΔF-injected oocytes was 8.8 ± 0.26 s (*n* = 24), which was significantly higher (ANOVA single factor, P \< 0.01) than full-length rTR~α~1-expressing oocytes (7.9 ± 0.38 s, *n* = 22) and the water-injected control group (7.2 ± 0.24 s; *n* = 30; [Fig. 10](#fig10){ref-type="fig"}, a and c). Together, these data strongly indicate that the regulation of Ca^2+^ signaling by T~3~-activated TRs requires their localization within mitochondria.

![**The truncated rTR** ~**α**~ **1ΔF regulates intracellular Ca** ^2**+**^ **release.** (a) Spatio-temporal stacks of IP~3~-induced Ca^2+^ wave activity in control oocytes compared with oocytes expressing rTR~α~1ΔF or rTR~α~1ΔF. TR expressing oocytes were treated with 100 nM T~3~ 10--15 min before IP~3~ (∼300 nM) injections and confocal imaging. (b) Western blots of rTR~α~1 and rTR~α~1ΔF expression levels in experimental oocytes. (c) Histogram of the average interwave periods for each group (*n* values in parentheses). Note that rTR~α~1ΔF has significantly longer periods even though its expression levels are lower than those of full-length rTR~α~1. The asterisks (\*\*) indicate statistical significance with P \< 0.01 using ANOVA single factor.](200409011f10){#fig10}

Discussion
==========

In this work, we report that the acute exposure of oocytes expressing mitochondrially targeted TR to T~3~ regulates IP~3~-mediated Ca^2+^ wave activity. We observed a T~3~-bound TR induced increase in the Ca^2+^ wave period and amplitude. These changes in Ca^2+^ activity were similar to those observed in *Xenopus* oocytes when mitochondria were energized with respiratory chain substrates ([@bib28]). In that report, the modulation of IP~3~-mediated Ca^2+^ release was due to an increase in mitochondrial Ca^2+^ uptake via an increase in the ΔΨ. Our current work is consistent with this model because we could inhibit the effects of T~3~-bound TRs by inhibiting mitochondrial Ca^2+^ uptake with Ru~360~. We also directly demonstrated that T~3~ exposure increased ΔΨ in oocytes expressing TRs. An increase in ΔΨ could be attributed to either a direct effect on electron transport or to a decrease in proton leak ([@bib17]; [@bib16]; [@bib19]). The application of T~3~ to mitochondria has been reported to decrease proton leak in several preparations ([@bib10]; [@bib51]). However, we found that T~3~ exposure increases O~2~ consumption in TR-expressing oocytes. An increase in the rate of O~2~ consumption is not consistent with a decrease in proton leak. Together, our data favors the conclusion that T~3~-bound TR regulates Ca^2+^ activity by increasing ΔΨ via an increase in proton pumping by the respiratory chain.

Application of thyroid hormones to mitochondria has long been known to increase metabolism ([@bib53]). Mitochondria were also known to be target organelles of T~3~ accumulation in cells ([@bib58]; [@bib37]). However, a mitochondrial hormone receptor that mediated these effects has never been conclusively identified. [@bib54]([@bib55]) initially suggested that the adenine nucleotide translocator (ANT) bound to T~3~ with high affinity. [@bib46] also suggested that thyroid hormone had its specific mitochondrial target site at the matrix side of ANT. They found that bongkrekic acid, a membrane-permeant inhibitor of ANT, blocked a thyroid hormone-induced release of Mg^2+^ from mitochondria. On the other hand, Wrutniak and coworkers ([@bib63]) found no evidence demonstrating a direct interaction between ANT and T~3~. Our data indicate that ANT alone is not the thyroid hormone receptor that mediates the regulation of mitochondrial metabolism. Rather, our data reveal that a mitochondrial targeted TR is a required element of acute thyroid hormone regulation of metabolism. The use of *Xenopus* oocytes in these experiments was crucial in this determination because oocytes do not express endogenous TRs ([@bib64]; [@bib29]). The ubiquitous expression of endogenous TRs would have hidden this finding in earlier studies.

The ability of specific thyroid hormone receptors to target mitochondria has been demonstrated by other investigators. A truncated form of rat TR~α~1 (rTR~α~1ΔF) and not its full-length form, localized to the matrix of mitochondria ([@bib2]; [@bib62]; [@bib9]). Our work corroborated these reports and further demonstrated that the xTR~β~A1, which is highly similar to rTR~α~1ΔF, targeted the mitochondria. Casas and coworkers ([@bib9]) reported that mitochondrial activity was stimulated by overexpression of p43 (mitochondria-targeted, truncated-TR~α~), which in turn, stimulated mitochondrial genome transcription of some enzyme units that played a role in the respiratory chain. The p43 protein had the same affinity to T~3~ as the full-length TR~α~ to bind to the D-loop of two mt-TREs in the mitochondria, leading to mitochondrial protein synthesis ([@bib9]). Their data suggested that p43 bound to mt-TREs as a homodimer because no RXR-isoform in the mitochondrial extract was detected ([@bib9]). Hadzic suggested that the NH~2~ terminus of TRs plays a role in TR-homodimerization in mitochondria ([@bib22]). Together, these studies demonstrated that mitochondrial-targeted TRs could regulate mitochondrial metabolism by initiating transcription. However, our results cannot be accounted for by this mechanism of action. Specifically, transcriptionally inactive TR mutants modulated Ca^2+^ wave activity with the same efficacy as the wild type, xTR~β~A1. We confirmed that xRXR~α~ was required for xTR~β~A1 to transactivate a reporter gene in our system, but more importantly, the presence of xRXR did not affect the ability of xTR~β~A1 to modulate Ca^2+^ activity. Thus, we concluded that the mechanism by which T~3~-activated TRs regulate Ca^2+^ signaling cannot be attributed to transcription.

Nongenomic effects of various steroid receptors have been reported for mineralocorticoids ([@bib38]; [@bib66]), glucocorticoids ([@bib5]; [@bib6]), gonadal steroids ([@bib42]; [@bib60]; [@bib32]; [@bib20],[@bib21]; [@bib36]), vitamin D3 ([@bib49]), and thyroid hormone ([@bib25]; [@bib12], [@bib13]; [@bib45]). Most of these studies proposed the presence of specific membrane-bound receptors for nongenomic effects; however, specific receptors were not cloned or identified. For thyroid hormones in particular, [@bib13] suggested that the mechanism of the nongenomic effects of thyroid hormone may not require TRs, and could involve actions of the hormone itself on signal transduction pathway via specific G protein--coupled protein. Recent work by [@bib47] identified an endogenous, rapid-acting derivative of thyroid hormone that is a potent agonist of the G protein-coupled trace amine receptor (TAR1). Activation of TAR1 increased cAMP production, which in turn, would active protein kinase A and phosphorylation of multiple proteins in cells. Our results do not exclude a potential role of second messenger systems in the mechanism of action of T~3~ on mitochondria. Rather, they demonstrate that classic TRs, those that have long been known to regulate gene transcription, will also acutely regulate mitochondrial activity when bound with T~3~. Stimulation is dependent on mitochondrial targeting of the TR, but not on its ability to initiate transcription. Together, these observations reveal a nontranscriptional pathway for modulation of intracellular Ca^2+^ signaling via T~3~/TR-stimulated mitochondrial metabolism.

The discovery of T~3~/TR-regulated Ca^2+^ signaling is potentially important for several reasons. First, any process that acutely regulates intracellular Ca^2+^ release will impact the multitude of Ca^2+^-sensitive cellular processes ranging from contractility and secretion to proteolysis and cell death. Second, the ability of a steroid hormone to increase proton pumping provides a rapid method to increase metabolism in response to short-term energy requirements; for example, during increased neuronal activity or during a transient increase in muscle activity. Third, and potentially more importantly, a rapid increase in mitochondrial Ca^2+^ uptake could protect cells under conditions of stress. Mitochondria have long been recognized for their capacity to sequester large Ca^2+^ concentrations under pathological conditions ([@bib18]). The ability to transiently remove Ca^2+^ from the cytosol could be used to minimize tissue damage after stroke in neuronal tissue or to reduce the instability of cardiac cells after periods of hypoxia. Clearly, the identification of a mitochondrial receptor for thyroid hormone-induced increases in metabolism offers a new pharmacological target from which it will be possible to regulate a broad range of physiological and pathological processes.

Materials and methods
=====================

Expression vector construction
------------------------------

The coding fragments of rat TR~α~1 cDNA, *Xenopus* RXR~α~ (a gift from R.M. Evans, The Howard Hughes Medical Institute, Chevy Chase, MD, and The Salk Institute for Biological Studies, La Jolla, CA) were amplified by PCR with a forward primer 5′-acgtggatccatggaacagaagccaagcaaggtg-3′ (for rTR~α~1), 5′-acgtggatccatgagttcagcagccatggacaccaaacat-3′ (for xRXR~α~) containing a BamHI site, and a reverse primer, 5′-atcgaagcttttagacttcctgatcctcaaagacctc-3′ (for rTR~α~1), 5′-atcgaagcttttaagtcatttggtgaggggcttccagcat-3′ (for xRXR~α~) containing a HinDIII site. The PCR products were then subcloned into the *Xenopus* oocyte expression vector, pGEM-HeNot between the BamHI and HinDIII sites ([@bib7]). All restriction enzymes were purchased from Life Technologies. The truncated form of rTR~α~ · (rTR~α~1ΔF) was generated by PCR at the second ORF of rTR~α~1 cDNA using a forward primer, 5′-acgtggatccatgtcagggtatatccctagttacc-3′ containing a BamHI site, and a reverse primer, 5′-atcgaagcttttagacttcctgatcctcaaagacctc-3′ containing a HinDIII site. The PCR product was placed into the pGEM-HeNot vector between the BamHI and HinDIII sites.

*Xenopus* TR~β~A1 was amplified by PCR with primers 5′-gctaggatccatggaagggtatatacccagctacttgg-3′ and 5′-atcgaagcttctagtcctcaaacacttccaagaacagtggggg-3′ and subcloned into vector pGEM-HeNot between the BamHI and HinDIII sites to create pGEM-HeNot-xTR~β~A1. *Xenopus* mutant xTR~β~A1-ΔNLS had its NLS removed by modifying the sequence from KR to AA. xTR~β~A1ΔpBox-NLS had the same NLS modification as well as the pBOX deletion of CEGCK within the DBD. Both mutants were generated by QuikChange site-directed mutagenesis (Stratagene) using pGEM-HeNot-xTR~β~A1 as a template. The forward primer for xTR~β~A1NLS was 5′-ggttttggatgacaacgcagctttggcaaaaagaaagc-3′ and the reverse complement primer was 5′-gctttctttttgccaaagctgcgttgtcatccaaaacc-3′. For the double mutation, pGEM-HeNot-xTR~β~A1NLS was used as a template. The forward primer for xTR~β~A1ΔpBox-NLS was 5′-gggtatcattatagatgtatcaccggcttttttagaagaactattcag-3′ and the reverse compliment primer was 5′-ctgaatagttcttctaaaaaagccggtgatacatctataatgataccc-3′. All mutations were confirmed by nucleotide sequencing (UTHSCSA DNA core facility).

In vitro transcriptions and oocyte protocols
--------------------------------------------

Synthetic mRNA was prepared as described previously ([@bib7]). In brief, the pGEM-HeNot vector containing cDNA template was linearized by a NotI restriction enzyme. From the linearized templates, mRNA was generated using the T7 promoter (MEGAscript; Ambion). Cap analogue, m^7^G(5′)ppp(5") (Ambion) was added to the reaction. The mRNA products were quantified by 1% agarose gel and spectrophotometry. RNase-free synthetic RNAs were resuspended at a concentration of 1.5--2.0 μg/μl and stored in aliquots of 3 μl at --80°C.

Stage VI oocytes were obtained from adult female *Xenopus laevis*. After defolliculation, oocytes were incubated in MBS (in mM: 88 NaCl, 1 KCl, 0.41 CaCl~2~, 0.33 Ca(NO~3~)~2~, 0.82 MgSO~4~, 2.40 NaHCO~3~, 10 Hepes, pH 7.5) at 18°C. mRNA was injected into the oocytes by a 50-nL bolus using a positive pressure injector (Nanoject; Drummond Scientific Co.). Control oocytes were injected with diethyl pyrocarbonate--treated water. Oocytes were incubated at 18°C for 2--3 d to allow full expression of proteins in MBS supplemented with antibiotics streptomycin, penicillin, and fungizone (GIBCO-BRL). Media was changed daily. Unhealthy oocytes were discarded daily.

Imaging acquisition and analysis
--------------------------------

Ca^2+^ wave activity was imaged as described previously ([@bib7]). In brief, oocytes were injected with 50 nl of a fluorescent Ca^2+^ sensitive dye (0.25 mM, Oregon green BAPTA2-cell impermeant; Molecular Probes) and incubated for 30--60 min before the experiment. Images were acquired with a confocal laser-scanning microscope (model PCM2000; Nikon) attached to an inverted microscope (model TE200; Nikon) at the rate of 1.5 images/s. We used a 10× 0.45 NA objective (UVFLUOR; Nikon). Each group of mRNA-injected oocytes was randomly assigned into two subgroups, one was exposed to 100 nM of T~3~ for 10 min and the other was untreated with T~3~. Ca^2+^ wave activity was initiated by injecting a 50-nl bolus of 6 μM IP~3~. The Ca^2+^ waves were analyzed with ANALYZE software (The Mayo Foundation, Rochester, MN). Statistical significance was calculated by either one-factor ANOVA or a *t* test as indicated.

ΔΨ was estimated as described previously ([@bib33]). In brief, 200 nM TMRE (Molecular Probes) was added to the bath and images were acquired with a 60× 1.4 NA objective on the Nikon PCM2000 custom adapted for two-photon imaging. TMRE was excited at 800 nm using a Ti-sapphire Coherent Mira 900 Laser pumped with a 5W Verdi laser (Coherent Inc.). Laser intensity was attenuated with a neutral-density filter wheel such that no detectable photobleaching of TMRE was observed.

Transcriptional activity assay
------------------------------

The transcriptional activity of TR and mutants were confirmed by using a reporting vector with the thyroid response element (TRE) as a cis-acting enhancer for the SEAP gene (Mercury Pathway Profiling SEAP System2; CLONTECH Laboratories, Inc.). The negative control vector (pSEAP^(−ve)^) lacks the enhancer element, but contains a promoter and SEAP reporter gene. Oocytes in each group were injected with mRNA (0.5 μg) and vector (0.5 μg) as designated, and incubated in 1 ml MBS with 100 nM T~3~, and/or RA for 3 d. Media was collected and replaced every 24 h for 3 d. Collected media from each group was pooled, concentrated (Amicon ultra 10000 MWCO; Millipore) to 40 μl and run on a 10% SDS-PAGE. Oocyte cytosolic extract from each group was prepared and loaded onto 10% SDS-PAGE at amounts equivalent to 2.5 oocytes per lane. SEAP was detected with polyclonal rabbit anti--human SEAP antibody (Zymed Laboratories, Inc.). HRP-conjugated secondary antibody (Jackson ImmunoResearch Laboratories Inc.) was used and visualized by chemiluminescence (PerkinElmer).

Western blot analysis
---------------------

Oocytes were washed twice times in homogenization buffer (in mM: 15 Tris-HCl, 140 NaCl, 250 sucrose, 1% Triton X-100, Complete protease inhibitor cocktail) at a concentration of 40 μl/oocyte. Washed oocytes were homogenized and centrifuged at 4,500 *g* for 15 min at 4°C. The supernatant was collected and loaded at 0.5 oocytes per lane onto 10% SDS-PAGE. TRs and mutants were detected with monoclonal mouse anti--human TRs antibody (MA1-215; Affinity BioReagents, Inc.). xRXR~α~ was detected with polyclonal rabbit anti--human RXRs antibody (Sc-774; Santa Cruz Biotechnology, Inc.). HRP-conjugated secondary antibody (Jackson ImmunoResearch Laboratories Inc.) was used and visualized by chemiluminescence (PerkinElmer).

Cytosolic and mitochondrial extract preparations
------------------------------------------------

300 oocytes in each group (water, xTR~β~A1, rTR~α~1, rTR~α~1ΔF) were allowed to express for 3 d and then treated with 100 nM T~3~ for 15 min at RT. Oocytes were washed twice times with buffer A (in mM: 190 sorbitol, 1 CaCl~2~, 10 TES, pH 7.4) and resuspended in buffer A at a final volume of 500 μl. Oocytes were sequentially homogenized with a hand-held homogenizer and centrifuged at 1,000 *g* for 5 min at 4°C. The supernatant was transferred to new tube and centrifuged at 14,000 *g* for 15 min at 4°C. Supernatant and pellet were collected separately. The pellet, which contained mitochondria, was washed several times with buffer B (in mM: 195 sorbitol, 5 EDTA, 5 TES, pH 7.4) and spun at 1,000 *g* for 5 min at 4°C to eliminate contaminants. The mitochondrial portion was finally obtained by centrifugation at 14,000 *g* for 15 min at 4°C. Mitochondria in each group were washed twice by resuspending in buffer B, centrifuged again at 14,000 *g* for 15 min at 4°C and lysed in the presence of 1% Triton X-100. The cytosolic fraction was centrifuged at 100,000 *g* for 15 min at 4°C to eliminate contaminating membranes.

O~2~ consumption assay
----------------------

A biological O~2~ monitor (model 5300; YSI Inc.) was used to measure O~2~ consumption. 200 oocytes in each group were loaded into a 2-ml O~2~ probe chamber avoiding contact of the oocytes with the O~2~ probe. 1.5 ml of MBS was added to the chamber and the system was allowed to stabilize for 15 min. The medium was subsequently exchanged with 1.25 ml of fresh MBS solution and O~2~ consumption was monitored for 30 min. The media was exchanged again with MBS containing 100 nM T~3~ and O~2~ consumption was followed for the next 30 min. The slope of O~2~ levels was calculated before and after the addition of T~3~.
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